Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Slides:

Advertisements

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Advertisements

Marko Niemimaa, M. D. , Seppo Heinonen, M. D. , Maija Seppälä, Ph. D

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.

Antagonists in poor-responder patients

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Age at menarche: a predictor of diminished ovarian function?

Knut Gjelland, M. D. , Seth Granberg, M. D. , Ph. D

Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada Natalie Dayan, M.D., Andrea Lanes, M.Sc.,

Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration Jean-noêl Hugues,

Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

James P Toner, M.D., Ph.D. Fertility and Sterility

A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates Paul B. Marshburn, M.D., Mark Alanis,

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program Fady I Sharara, M.D.,

Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF John Y Phelps, M.D., Adam S Levine,

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age Sanja Kupesic, M.D., Ph.D., Asim Kurjak,

Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective.

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.

In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option? Marine Quinquin,

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

Two interesting cases of ovarian pregnancy after in vitro fertilization–embryo transfer and its successful laparoscopic management Selvaraj Priya, M.D.,

Intracytoplasmic sperm injection in partial globozoospermia

Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis Micah J. Hill, D.O., Brian.

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Marcus W. Jurema, M. D. , Andrea D. Vieira, M. D

Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study Ahmet Erdem, M.D., Mehmet Erdem,

Success of intrauterine insemination in women aged 40–42 years

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis Roberto Matorras, M.D., Ph.D., Carmen Osuna,

Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement Fertility and Sterility Volume 102,

Mark D Hornstein, M. D. , Owen K Davis, M. D. , Joe B Massey, M. D

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Frequency and effect of vaginal bleeding on pregnancy outcome during the first 3 weeks after positive β-hCG test results following IVF-ET Glen E Hofmann,

Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular.

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D.

Serum and follicular fluid monocyte chemotactic protein-1 levels are elevated in obese women and are associated with poorer clinical pregnancy rate after.

Effect of endometriosis on in vitro fertilization

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Fertility and Sterility

Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro.

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Efstratios M Kolibianakis, M.D., Kostas.

Comparison of the effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in infertile patients Saeed Alborzi, M.D., Shahdokht.

Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines Dolors Manau,

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Murat Arslan, M.D.,

Luteal phase support Fertility and Sterility

Jeffrey M Goldberg, M. D. , Edward Mascha, M. S. , Tommaso Falcone, M

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

When is clomiphene or gonadotropin intrauterine insemination futile

Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following.

Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect.

Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success G.Wright Bates, M.D., Elizabeth S Ginsburg, M.D.

Increased pregnancy rates after ultralong postoperative therapy with gonadotropin- releasing hormone analogs in patients with endometriosis Dagmar Rickes,

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels Antonio Requena, M.D., María Cruz, Ph.D.,

Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility William E Roudebush, Ph.D.,

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Ernesto Bosch,

Emotional adaptation following successful in vitro fertilization

Presentation transcript:

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve Glen E Hofmann, M.D., Ph.D., Jane Khoury, M.S., Chad Michener, M.D. Fertility and Sterility Volume 78, Issue 1, Pages 47-50 (July 2002) DOI: 10.1016/S0015-0282(02)03162-X

FIGURE 1 Pregnancy rates in the IUI and IVF groups as a function of the P/E2 ratio. Pregnancy rates did not differ between groups on the basis of the ratio. Hofmann. PE2 ratio and diminished ovarian reserve. Fertil Steril 2002. Fertility and Sterility 2002 78, 47-50DOI: (10.1016/S0015-0282(02)03162-X)